7-94426732-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000089.4(COL1A2):​c.3105+202G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.764 in 642,502 control chromosomes in the GnomAD database, including 188,575 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 43805 hom., cov: 31)
Exomes 𝑓: 0.77 ( 144770 hom. )

Consequence

COL1A2
NM_000089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.250

Publications

20 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 7-94426732-G-T is Benign according to our data. Variant chr7-94426732-G-T is described in ClinVar as Benign. ClinVar VariationId is 1268257.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.885 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A2NM_000089.4 linkc.3105+202G>T intron_variant Intron 46 of 51 ENST00000297268.11 NP_000080.2 P08123A0A0S2Z3H5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A2ENST00000297268.11 linkc.3105+202G>T intron_variant Intron 46 of 51 1 NM_000089.4 ENSP00000297268.6 P08123

Frequencies

GnomAD3 genomes
AF:
0.758
AC:
115051
AN:
151846
Hom.:
43763
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.715
Gnomad AMI
AF:
0.814
Gnomad AMR
AF:
0.798
Gnomad ASJ
AF:
0.710
Gnomad EAS
AF:
0.907
Gnomad SAS
AF:
0.669
Gnomad FIN
AF:
0.792
Gnomad MID
AF:
0.650
Gnomad NFE
AF:
0.767
Gnomad OTH
AF:
0.731
GnomAD4 exome
AF:
0.765
AC:
375429
AN:
490538
Hom.:
144770
Cov.:
5
AF XY:
0.758
AC XY:
198994
AN XY:
262368
show subpopulations
African (AFR)
AF:
0.709
AC:
9423
AN:
13298
American (AMR)
AF:
0.825
AC:
19420
AN:
23526
Ashkenazi Jewish (ASJ)
AF:
0.713
AC:
10834
AN:
15204
East Asian (EAS)
AF:
0.932
AC:
29501
AN:
31652
South Asian (SAS)
AF:
0.656
AC:
31917
AN:
48686
European-Finnish (FIN)
AF:
0.787
AC:
24938
AN:
31684
Middle Eastern (MID)
AF:
0.656
AC:
1540
AN:
2346
European-Non Finnish (NFE)
AF:
0.766
AC:
227066
AN:
296402
Other (OTH)
AF:
0.749
AC:
20790
AN:
27740
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
5054
10108
15161
20215
25269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1052
2104
3156
4208
5260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.758
AC:
115151
AN:
151964
Hom.:
43805
Cov.:
31
AF XY:
0.757
AC XY:
56263
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.715
AC:
29572
AN:
41366
American (AMR)
AF:
0.798
AC:
12187
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.710
AC:
2461
AN:
3466
East Asian (EAS)
AF:
0.907
AC:
4690
AN:
5172
South Asian (SAS)
AF:
0.669
AC:
3224
AN:
4816
European-Finnish (FIN)
AF:
0.792
AC:
8379
AN:
10578
Middle Eastern (MID)
AF:
0.661
AC:
193
AN:
292
European-Non Finnish (NFE)
AF:
0.767
AC:
52159
AN:
67976
Other (OTH)
AF:
0.732
AC:
1547
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1415
2831
4246
5662
7077
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
854
1708
2562
3416
4270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.762
Hom.:
62265
Bravo
AF:
0.759
Asia WGS
AF:
0.793
AC:
2757
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
7.5
DANN
Benign
0.56
PhyloP100
-0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2621215; hg19: chr7-94056044; API